908 Devices Inc. Common StockMASS
Recorded

908 Devices Inc. Common Stock Canaccord Genuity's 46th Annual Growth Conference

Review the key takeaways and the transcript of this earnings call.

PeriodFY 0Duration26 minParticipants3

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Austin MoellerAerospace and Defense Technology Analyst

All right. Hi everybody. I'm Austin Moeller. I'm the aerospace and defense technology analyst here at Canaccord Genuity. Today, we are joined by Kevin Knopp and Joe Griffith from 908 Devices. We are going to talk about mass spectrometers and why they're so important for military and law enforcement. I guess just to start off, could you just give a brief overview of the company and talk about the company's transition from being a medical device business into the defense and public safety market?

Kevin KnoppCEO and Co-Founder

Yeah, absolutely. Thanks so much for hosting us here today, Austin. I really appreciate the opportunity. Yeah, so 908 Devices is creating a category of handheld detection solutions aimed at public safety and defense customers, really geared towards chemical detection and drug detection applications specifically. The fentanyl crisis, nitazenes, xylazine, other compounds of the synthetic opioids, as well as toxic industrial chemicals, and having a complete suite of handheld devices to address those applications. From a medical device, as you put it, so 908 really is coming back to our roots a little bit here. When we started the company in 2012, we built a handheld mass spectrometry technology, which is taking a lab-grade technology of mass spectrometry and taking it out of the lab and bringing it to the user that could have access at the point of need for immediate answers.

Kevin KnoppCEO and Co-Founder

The pinnacle of that to us was a battery-powered smallest that we could do at the time and developing a solution that didn't exist, new category, and we did so with purpose-built for military and security applications. Now you fast-forward, that mass spectrometry is a platform, and we continue to look through applied areas and markets as well as into life sciences. When Austin's mentioning the medical devices, when we were at the throes of our IPO in 2020, we really were gearing up and launching products into the bioprocessing, biopharma space. About 15 months ago, we've divested that business line, and now we're fully focused on the category of defining handheld detection for these public health, safety, and defense markets.

Kevin KnoppCEO and Co-Founder

In many ways, coming back to our roots, an area that we know well, and an area that we've seen a lot of strong growth over those years.

Austin MoellerAerospace and Defense Technology Analyst

How important is real-time chemical analysis for law enforcement, given the extremely long wait times to get results from laboratories?

Kevin KnoppCEO and Co-Founder

Yeah. It is so important because of that fact. We serve law enforcement customers globally, and we serve fire and hazmat customers globally. Speed is of essence to both categories. Starting with the law enforcement side, you are absolutely right. We work with customers that will tell us the backlog of their forensics labs using mass spec and other associated technologies in those labs can be 6 months or 9 months. What that means in practice is in a law enforcement scenario, if someone is arrested, held, charged for a drug case, they may get released while waiting for those results. Then people are back on the street or not getting into therapy or getting other problems associated to it. So by using our technology, they are speeding it up.

Kevin KnoppCEO and Co-Founder

They are literally getting an immediate answer, maybe about 30 seconds or so, depending on our technology that we have, and they can use that as presumptive evidence in the case of many of our products, approved by the state, and then they can use that for probable cause or for prosecution faster using those results. So time matters a lot. We work a lot with the Ohio Attorney General's Office, proving out this model. They have been strong supporters of this exact fact, that their lab is backlogged, and in this way, they can triage it, they can move cases through faster. Then the same is true on the fire side. Answers matter quickly. So again, we are bringing more closer to lab-grade results right there in the field.

Kevin KnoppCEO and Co-Founder

In the case of recent hazmat instances, Los Angeles, other areas where tanks were leaking, having technology that can come in right away, identify and quantify an unknown gas, and decide the hazard, what is around me, for my community, the exposure to personnel, it is incredibly important to have speed.

Austin MoellerAerospace and Defense Technology Analyst

Can you talk about some of the key differences in your product line between the VipIR, MX908, and the new NIRLab handheld device?

Kevin KnoppCEO and Co-Founder

Yeah, very much. Happy to do so. On the top right of this slide behind us here is our flagship, and that's our MX908. That's our flagship device. We've got about 3,000 of those in the field, in use across a lot of drug applications for Department of Corrections, a lot of applications for law enforcement, but also onto military and defense applications. Our flagship, it's our most sensitive device, measuring synthetic opioids through to chemical weapons through to non-traditional chemical agents. It's a very high sensitive, high specific device. Below that, we would have our VipIR product. Our VipIR is our newest FTIR product. That product is a very unique product that takes three technologies into one box to do bulk chemical identification.

Kevin KnoppCEO and Co-Founder

It takes a technology called FTIR, and it takes technology called Raman, and it combines it with algorithms layer to give a very confidence-inspiring answer because you have two orthogonal approaches looking at that sample. From an analyte perspective, it can measure 38,000 different analytes and then provide that confirmatory result of a bulk ID. Geared really for customs agencies, ports of entry, hazmat teams, and users of that nature. Then the third product you mentioned is our newest product through acquisition. I brought one today, I'd be happy to show after as well. But this is our NIRLab product.

Kevin KnoppCEO and Co-Founder

This is also a bulk identification product where you just take this and you touch it against a potential counterfeit pill, or a pile of a substance, and then there's about 400 different drug substances in here that it can ID in a few seconds, and it's all cloud connected through a subscription. It's the lowest price entry point of this product for us, and it's really meant for fast screening of routine police operations, police patrol operations on the drug detection side.

Austin MoellerAerospace and Defense Technology Analyst

If anyone's got a bag of drugs, we can test it.

Kevin KnoppCEO and Co-Founder

We can do it. Yeah.

Kevin KnoppCEO and Co-Founder

We can do it. Do you want to know what it is?

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

More recent earnings calls

View earnings calendar